Lack of emerging resistance mutations in 467 HBeAg− and HBeAg+ patients with chronic hepatitis B receiving Adefovir Dipivoxil for 48 weeks
- 30 April 2002
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 36, 137-138
- https://doi.org/10.1016/s0168-8278(02)80493-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: